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ANALYSIS OF THE REGULATION OF THE S. CEREVISIAE GENE PIR3
BY NON-CODING INTERGENIC TRANSCRIPTION
Robin Monteverde Ceschin, M.S.
University of Pittsburgh, 2012
Genome-wide studies have identified pervasive noncoding transcription across prokaryotic
and eukaryotic genomes. Although some of these noncoding RNAs (ncRNAs) are likely the
result of transcriptional noise, important regulatory functions have been elucidated for a
small fraction of these transcripts that have been studied in detail. Previous studies in our
lab have elucidated a regulatory mechanism in which transcription of the noncoding RNA,
SRG1, regulates expression of the adjacent gene SER3 by directing nucleosome occupancy
across the SER3 promoter, thereby blocking access of activators that induce transcription.
A significant portion of noncoding transcription near promoters of protein-coding genes
suggests a possible role in the regulation of transcription and initiation of these genes. In
this investigation, I describe the identification of a new site of gene regulation by intergenic
transcription at Saccharomyce cerevisiaePIR3 (Proteins with Internal Repeats 3), a gene
encoding a cell wall protein identified from RNA pol II genome-wide data. I use a new
method of disrupting transcription to assess the effect that loss of intergenic transcription
has on PIR3 expression. This led to the identification of a repressive function for intergenic
transcription in cis at PIR3.
Regulatory functions by ncRNAs have implications in human disease and development,
which is often the result of epigenetic changes leading to altered chromatin states. Particu-
larly, investigations of gene expression related to various cancers have provided examples of
ncRNAs that can be used as biomarkers in predicting the likelihood of metastasis and silence
tumor suppressor genes through epigenetic modifications. From a public health standpoint,
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studying the mechanisms by which ncRNAs regulate gene expression or the manner in which
epigenetic misregulation leads to disease will allow for more targeted therapies. Additionally,
identification of ncRNA is useful in itself as a source of biomarkers in cancer and genetic
diseases. This study has additional importance for the development of improved antifun-
gals in the fight against resistant pathogenic strains of yeast, an increasing public health
problem, particularly among immunocompromised patients. S. cerevisiae is a good model
for pathogenic strains of yeast in terms of studying genes and proteins involved in cell wall
regulation and biosynthesis which could aid in identifying effective therapies.
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1.0 INTRODUCTION
It has become increasingly apparent that transcription of non-protein-coding DNA (ncDNA)
occurs throughout eukaryotic and prokaryotic genomes, often times serving in regulatory
roles. This regulation can occur through the act of transcription or by the ncRNA products
[50]. Studies of gene regulation by ncRNAs are important based on their roles in human
development and disease (reviewed in [59, 23, 78, 50, 28]. Saccharomyces cerevisae serves as
a model organism for studies on gene regulation and function in eukaryotes.
1.1 TRANSCRIPTION OF PROTEIN CODING GENES
The complex and highly regulated process of mRNA transcription is performed by RNA
polymerase II (RNA pol II) a large complex consisting of 12 subunits: Rpb1-12 (reviewed in
[70]). There are three major stages of transcription: initiation, elongation, and termination.
Each stage is highly regulated by trans-acting transcription factors and cis-acting regulatory
elements. Eukaryotic cells have the added complexity of DNA wrapped around chromatin,
creating an obstacle to DNA access that is overcome by various factors. (Figure 1.1).
1.1.1 Transcription Initiation
The transcription cycle begins with the binding of an activator protein to upstream activating
sequences (UAS) of gene promoters. The core promoter elements include consensus DNA
binding sequences, such as the TATA box, and the transcription initiation site. Bound
activators recruit transcription factors in an ordered fashion to assemble the pre-initiation
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Figure 1.1: Overview of general transcription of protein coding genes. Diagrammatic
overview of general transcripion of protein coding genes. A) Formation of the PIC with RNA
pol II and GTFs at the core promoter. B) Transcription elongation is mediated through
phosphorylation of RNA pol II CTD at Ser5 as well as active transcription marks such as
H3 K4 trimethylation and H3 K9 and H3 K14 acetylation. C) Transcription termination
is mediated through phosphorylation of RNA pol II CTD at Ser2 leading to recruitment of
poly(A) processing factor CPSF and Ctsf. (see text for details).
2
complex (PIC) at the core promoter. The PIC is composed of RNA polymerase II (RNA
pol II) and general transcription factors (GTFs), including, TFIIA, TFIIB, TFIID, TFIIE,
TFIIF, and TFIIH. PIC formation is triggered by the binding of TATA-binding protein
(TBP), a subunit of TFIID, to the core promoter element through recognition of a consensus
sequences (reviewed in [40]). The consensus sequence for TBP is the AT-rich TATA box;
however, many promoters lack this element with no consequence to PIC formation. TFIIA
and TFIIB are next recruited to stabilize the TFIID-DNA interaction and aid in start site
selection. RNA pol II then associates with the forming PIC, an interaction that is stabilized
by the simultaneous binding of TFIIF. TFIIH and TFIIE are last to bind to the PIC. The
TFIIH helicase activity opens the promoter sequence to begin transcription (reviewed in
[67]).
The C-terminal domain (CTD) of Rpb1, the largest subunit of RNA pol II, consists of
tandem haptapeptide repeats (YSPTSPS) (27 repeats in yeast and 52 in humans). RNA
pol II is hypo-phosphorylated at the time of PIC assembly, but phophorylation states for
serines at positions 2, 5, and 7 of the CTD repeats, are necessary depending on the stage
of transcription. Following PIC assembly, Kin28, the yeast homologue of human Cdk7
kinase, phophorylates Serine 5 (Ser5), stimulating RNA pol II clearance of the promoter
and productive transcription. After approximately 25 nucleotides (nt) have been produced,
the mRNA capping enzyme recognizes Ser5-P and adds the methylguanosine cap to the 5’
end of nascent mRNA, a mark of productive transcription (reviewed in [40]). Di- and tri-
methylation of histone H3 at lysine 4 (H3 K4) at the promoter leads to recruitment of histone
acetyltransferases (HATs) that acetylate histone resides such as histone H3 K9 and K14 and
histone H4 K16 of nucleosomes near the promoter. These histone marks are important for
creating a chromatin environment that will promote RNA pol II processivity (reviewed in
[67]).
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1.1.2 Transcription elongation
Following promoter clearance, RNA pol II moves into the coding sequence to begin the phase
of transcription elongation. Elongation is facilitated by a large number of protein coding
genes that co-localize with RNA pol II across transcribing genes. These include histone
chaperones, histone modifying complexes and other protein complexes that support these
actions. Again, modification of the RNA pol II CTD occurs, including a loss of phospho-
Ser5 and addition of phosphate to Serine 2 (Ser2), mediated by the SSU72 phophatase and
Ctk1 (P-TEFb in humans), respectively. Phospho-Ser2 levels increase toward the 3’ end of a
gene and stimulate recruitment of cleavage and polyadenylation factors for 3’ end processing
of the mRNA. An important histone modification associated with elongation is histone H3
K36 methylation, mediated by methlytransferase Set2. Methylated histone H3 K36 recruits
Histone deacetylase (HDAC) Rpd3S which removes acetyl-histone modifications returning
the chromatin to a non-permissive state, preventing aberrant, or cryptic, transcription from
within genes (reviewed in [67].
1.1.3 Transcription termination
Transcription termination is marked by the dissociation of RNA pol II from the 3’ end of
the transcribing unit. Termination occurs in the context of two separate pathways, the
poly(A) signal-dependent pathway, and the Nrd1-Nab3-Sen1-dependent pathway. In the
poly(A)-dependent pathway, transcription of the poly(A) signal, a conserved ’5-AAUAAA-
3’ sequence followed by a G/U-rich sequence towards the 3’ end of genes, is followed by RNA
pol II pausing. The phospho-Ser2 of the RNA pol II CTD recruits termination complexes,
such as the cleavage and polyadenylation specicity factor (CPSF), the cleavage stimulatory
factor (CstF) and Poly(A) polymerase, to the 3’ end of completed pre-mRNAs. CPSF binds
to the transcribed poly(A) track and initiates endoribonucleolytic cleavage of the transcript
followed by addition of a poly(A) track by Poly(A) polymerase (reviewed in [67]). The
non-poly(A) 3’ end formation machinery includes RNA binding proteins Nrd1 (nuclear pre-
mRNA down-regulation) and Nab3 (nuclear polyadenylated RNA-binding) and the RNA
helicase Sen1 [26]. The Nrd1-Nab3 pathway recruits the TRAMP polyadenylation complex,
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of which the Poly(A) polymerase Trf4 is a member, to nascent non-poly(A) transcripts,
leading to 3’ end processing and/or exosomal degradation [54]. This pathway is utilized in
termination of snoRNA, snRNAs, and some long non-coding RNAs, such as cryptic unstable
transcripts (CUTs) (reviewed in [48]), [15, 54].
1.1.4 Chromatin and transcription
In eukaryotes, DNA associates with histone proteins to form the compact chromatin structure
necessary for securing the genetic code in the nucleus. Chromatin is composed of nucleo-
somes, which consist of an octamer of histones, around which 147bp of DNA is wrapped
1.65 times. The octamer of histones contains two copies of histones H3 and H4 and two
dimers of histones H2A and H2B. Histones are positively charged proteins that fold to form
the globular nucleosome structure. The unstructured amino-terminal and C-terminal tails
extend from the core nucleosome [43], making contact with DNA or other histone proteins
(reviewed in [40]). The chromatin template is formed from the repetition of nucleosomes
along the DNA template every 100-200bp [37]. Histone H1 binds to linker DNA between
nucleosomes, allowing for the folding of nucleosome into higher order chromatin structure
(reviewed in [40]). In yeast, each histone is encoded by two genes and are transcribed as
four gene pairs: copies one and two of histone H3 and H4 (HHT1-HHF1 and HHT2-HHF2 )
and copies one and two of histone H2A and H2B (HTA1-HTB1 and HTA2-HTB2 ) [43]. The
number of histone copies varies among eukaryotes. For example mice and humans have >
50 copies and drosophila have ∼100 copies of histone genes. The low copy number in yeast
have facilitated studies on the role of histone in various cellular processes (reviewed in [62]).
Chromatin compaction creates an obstacle for DNA access by factors involved in tran-
scription, making the removal or disruption of histones necessary for RNA pol II to move
across the transcription unit. The eukaryotic system possesses three main mechanisms for
overcoming the chromatin barrier: ATP-dependent chromatin remodeling, addition of his-
tone modifications (ubiquitination, acetylation, methylation, phosphorylation), and histone
chaperone activity. Eukaryotic cells have four families of chromatin remodeling complexes,
Swi/Snf, Iswi, Chd, and Ino80, that disrupt nucleosome-DNA contacts through the use
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of ATP-hydrolysis to laterally slide or remove nucleosomes, aiding in access to gene reg-
ulatory elements such as activators. Post-translational histone modifications, particularly
histone acetylation, are important for overcoming repressive nucleosome architecture hin-
dering transcription initiation. Paf1 (polymerase-associated factor 1) complex (Paf1C) is a
conserved multisubunit complex that has been shown to facilitate transcription elongation
in eukaryotes by promoting transcription-dependent post-translational histone modifications
(reviewed in [13]). Histone chaperones are important for the removal and replacement of hi-
stones from promoters and transcribing sequences in order to both allow passage of RNA pol
II and restore repressive chromatin structure in the wake of RNA pol II preventing aberrant
transcription from within intragenic or cyrptic promoters. Two well known histone chaper-
ones include Spt6 and the FACT (Facilitates Chromatin Transactions) complex, of which
Spt16, Pob3, and auxiliary protein Nhp6 are members (reviewed in [62]).
1.2 YEAST AS A MODEL ORGANISM
In order to better understand regulation of eukaryotic gene expression, we use Saccharomyces
cerevisiae as a model organism. S. cerevisiae is a single cell eukaryote that can exist stably
in either a haploid or diploid state. In the haploid state, the genome is composed of 16
chromosomes ranging from 200-2,200 Kb. When the genome was fully sequenced in 1996,
approximately 6,183 ORFs were identified and 5,800 were considered to be potential protein
coding genes, with only 3.8% containing introns [16, 68]. Genetic analysis in yeast is relatively
easy compared to higher eukaryote. In addition to their amenable genetic qualities, S.
cerevisiae is fast growing (90 minute doubling time), inexpensive, and noninfectious [68].
The ease of genetic manipulation makes this organism ideal for genetic studies. Compar-
isons between yeast and other eukaryotes lead to the discovery that a considerable degree of
homology exists in both protein sequence and function, aiding studies in higher eukaryotes.
In addition, mammalian protein function can be studied directly by heterologously express-
ing human homologues in yeast [8].
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An important contribution made by yeast studies toward understanding human disease
was recognized in 2001 with the Nobel Prize in Physiology or Medicine, jointly awarded to
Leland H. Hartwell, R. Timothy Hunt, and Paul M. Nurse for their contributions to under-
standing key regulators of the cell cycle. Dr. Hartwell utilized S. cerevisiae in gene mutation
experiments that led to the discovery of CDC (cell division cycle) genes and their impor-
tance in proper regulation necessary to prevent uncontrolled cell growth or cancer. These
findings on cell cycle regulation turned out to be universally applicable to all eukaryotic
organisms, again attesting to the high degree of genetic and protein function homology that
exists between yeast and higher eukaryotes [58].
1.3 NONCODING RNA (NCRNA)
Important functional noncoding RNAs have long been known. Examples include ncRNAs
which are necessary for translation of mRNA into proteins, such as transfer RNAs (tRNAs)
and ribosomal RNAs (rRNAs). Other functional ncRNAs include those involved in RNA
processing, such as small nucleolar RNAs (snoRNAs), which function in pre-rRNA cleavage
(rRNAs), and small nuclear RNAs (snRNAs) which form the splicesome complex necessary
for the removal of introns from pre-mRNAs (reviewed in [18, 34, 48]).
Beyond the well studied examples of functional RNAs, the recent development of new
techniques and technology, such as RNA-deep sequencing, high-resolution tiling arrays, and
chromatin immunoprecipitation (ChIP) for transcriptome analysis has led to an explosion of
ncRNA identification in all organisms (reviewed in [28, 81, 4, 78, 50]). A major question has
been whether these ncRNAs serve important biological functions or represent transcriptional
noise. While many of these transcripts may represent transcriptional noise, the array of
regulatory functions found for ncRNAs has been steadily growing (reviewed in [78]). The
discovery of this new class of regulatory RNAs adds a level of complexity to our understanding
of gene regulation. Previously, studies on transcription centered around the idea that this
process was a means for protein production, not production of RNAs for gene regulation. In
gene expression studies in cancer cells, long noncoding RNAs (lncRNAs) have been identified
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that have roles in tumor supressor silencing. Additionally, a patient’s gene expression profile
in cancer cells allows for seemingly accurate predictions in whether the cancer will become
metastatic. Therefore, continuing to identify ncRNA and study their regulatory roles can
lead to a greater understanding of disease progression and which patients may benefit from
more aggressive preemptive treatment ([20] and reviewed in [59, 75]).
1.3.1 Classification of ncRNAs
ncRNAs represent a diverse class of molecules that vary in size, stability, and function. In
yeast, there are three classifications of ncRNAs based on stability: SUT, CUTs, and XUTs
(reviewed in [3]). These transcripts can be found either sense or anti-sense to protein-coding
genes. Stable unannotated transcripts (SUTs) are a group of stable non-coding transcripts,
that are capped and polyadenylated, exhibiting a median length of 761 nucleotides. XUTs
are Xrn1-sensitive unstable transcripts that are degraded by the cytoplasmic 5’ to 3’ exonu-
clease Xrn1, and are only detected in xrn1 deletion strains [74]. Cryptic unstable transcripts
(CUTs) are a recently described class of ncRNAs in yeast that vary in size (200-800bp) but
share the common feature of being rapidly degraded by the nuclear exosome such that these
transcripts are only detected in strains with deleted exosome components. Termination of
CUTs is dependent on the Nrd1-Nab3 pathway which recruits the TRAMP polyadenylation
complex, of which the poly(A) polymerase Trf4 is a member, marking them for degradation
by the exosome, accounting for the fast turnover of CUTs in cells [54, 80]. Rrp6 is a 3’ ex-
onuclease associated with the exosome that rapidly degrades cryptic or unstable transcripts,
making deletions of Rrp6 and/or Trf4 necessary for visualization of CUTs [54, 15].
In other eukaryotes, ncRNAs are described primarily based on size, and, in some cases
origin of transcription. Long noncoding RNAs (lncRNAs) are described as being greater
than 200 nucleotides in length with small noncoding RNAs (sRNAs) being less than 200 nu-
cleotides long, both tending to be associated with gene boundaries. For example, promoter-
associated sRNAs (PASRs) are transcribed near gene promoters, whereas those associated
with the 3’ ends of genes are termed terminator-associated sRNAs (TASRs)
[33]. microRNAs (miRNAs) are another well characterized group of small ncRNAs that are
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transcribed and target mRNA with complementary sequences leading to mRNA degradation
or translational repression (reviewed in [11]). These long noncoding RNAs can be transcribed
in the sense or anti-sense direction of protein coding genes, as well as from intronic sites (re-
viewed in [50]). In humans, short, polyadenylated and highly unstable transcripts known as
PROMPTs (for promoter upstream transcripts) have been identified that, like CUTs, are
only detectable in mutants of the human exosome (reviewed in [3]).
1.3.2 Multiple roles for ncRNAs in gene regulation
Long ncRNAs (lncRNAs) have been implicated in gene regulation in multiple ways including
affecting chromatin modifications, post-transcriptional processing, and preventing access of
transcription factors (reviewed in [50]). These regulatory functions can be performed in cis
or in trans.
1.3.3 Regulation of noncoding RNAs in trans.
Long noncoding RNAs can act in trans to mediate epigenetic regulation through altered chro-
matin states with implications in human disease and development. In these cases, the RNA
product is coordinated with the regulation of gene expression, often times by associating
with proteins that perform histone modifications. For example, X-chromosome inactivation,
important for maintaining proper gene dosage in mammalian females, is regulated by the
concerted action of ncRNAs Tsix and Xist. Tsix and Xist block or recruit, respectively, the
polycomb repressive complex (PRC2), which silences genes by promoting repressive H3 lysine
27 trimethylation (H3 K27me3) mark. Also, the human HOTAIR (Hox transcript antisense
RNA) ncRNA, transcribed from HOXC locus of the homeobox domain, recruits PRC2 to
the HOXD locus, inducing a repressive chromatin state, which is important for regulating
proper timing of gene expression (reviewed in [50]). Recently, misregulation of recruitment
of PRC2 by HOTAIR has been implicated in breast cancer metastasis with the finding that
HOTAIR can recruit PRC2 to tumor suppressor genes, resulting in their epigenetic silencing
[20, 75] (Figure 1.3.3).
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A cancer-associated virus, Kaposi’s sarcoma-associated herpesvirus (KSHV), produces
a polyadenylated nuclear RNA (PAN RNA) that interacts with host proteins in the nu-
cleus and is necessary for expression of late viral genes [7]. Recent data suggests that PAN
RNA activates KSHV gene expression through interaction with demethylases and methyl-
transferases resulting in the removal of repressive H3 K27me3 marks with the simultaneous
addition of the activating H3 K4me3 marks [66]. trans interactions of ncRNAs with tran-
scription factors can also act in repression, for example a ncRNA that interacts with TFIIB
prevents stable PIC formation, specifically at the human DHFR (Dihydrofolate reductase)
locus (reviewed in [78]). Antisense noncoding transcription can also affect gene regulation.
For example, the p15 human tumor supressor gene has been shown to be silenced by the
p15AS ncRNA transcribed from the 3’ end and across the promoter of p15, altering histone
modification that result in heterochromatin formation (reviewed in [23]).
1.3.4 Regulation by noncoding RNA is cis.
Transcription of ncRNAs in cis performs various regulatory functions, including nucleosome
remodeling, promoting histone modifications, and blocking promoter access. The Schizosac-
charomyces pombe fbp1+ gene is activated in response to glucose starvation through nucle-
osome remodeling by ncRNA transcription. At this locus, ncRNA transcription across the
promoter yields a chromatin structure that is open, making access by activators and tran-
scription factors possible (reviewed in [78]). Repressive histone marks can also be regulated
in cis. At the divergently transcribed GAL1 and GAL10 genes, transcription originating
from the 3’ end of GAL10 induces repressive histone modifications, such as H3 K36 methyla-
tion (reviewed in [23]). Transcription interference is another cis-acting regulatory mechanism
that results in blocking promoter access by activators or transcription factors as a result of
elongating noncoding transcription. Examples of this include activator eviction at ADH1
and ADH3 as a result of ZZR1 transcription across the promoter [5].
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Figure 1.2: Diagram of gene regulation by ncRNA. (A) Diagram of trans acting HO-
TAIR recruiting PCR2 to silence tumor supressor genes [20]. (B) Transcription interference
model at ADH1 where intergenic transcription of ZRR1 evicts the Rap1 activator protein
at the ADH1 promoter [5]. (C) Transcription in cis across the GAL10/GAL1 promoter
mediates recruitment of the Rpd3S HDAC resulting in repressive histone H3 K36 methyla-
tion [27, 57]. (D) Translation regulation by ncRNA by the B. burgderfori DsrABb sRNA.
At 23◦C the rpoS mRNA is in a hairpin formation which sequesters the Shine-Delgaro (SD)
sequence. At 37◦C, DsrABb binds to complementary sequence on rpoS mRNA, relaxing the
hairpin for ribosome access [44].
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1.3.5 Noncoding RNAs can regulate mRNA translation.
Beyond transcription regulation of gene expression, translation of mRNAs can be regulated
by ncRNA association. For example, translation of a virulence-associated gene in Borrelia
burgdorferi, the causative agent of Lyme disease, is indirectly dependent on a ncRNA. A
proposed mode of regulation for this small ncRNA (sRNA), DsrABb, is that it can rapidly
induce translation of the RpoS sigma factor required for transcription of the outer mem-
brane protein OspC, necessary for transmission of B.burgdorferi from tick to mammalian
host. Translation of the long rpoS mRNA is thought to be rapidly induced by the binding
of DsrABb which relaxes a proposed 5’ hairpin structure in the mRNA, which obscures the
Shine-Delgarno sequence necessary for translation [44] (reviewed in Samuels2011.
Another interesting example of ncRNA-mediated translation has been implicated in
Alzheimer’s disease. This ncRNA, β-site amyloid precursor protein (APP)-cleaving enzyme-
Antisense (BACE1-AS) is transcribed in the opposite direction of BACE1. The ncRNA
interacts with the mRNA at BACE1 for stabilization during translation. If BACE1-AS
transcription is increased, it may lead to increasingly stable BACE1 mRNA and thus higher
translation of this protein. Cleavage of the BACE1 target, APP, leads to the production of
amyloid β-peptide (Aβ), of which high levels have been implicated in neurological disorders,
such as Alzheimer’s disease (reviewed in[75]).
These studies make it is apparent that ncRNAs have a variety of distinct roles in gene
regulation. Some of these examples have implications in human disease and cancer. Studying
ncRNAs will lead to a greater understanding of how they regulate gene expression leading to
possible insights in cancer progression and prognosis. We can use our knowledge of ncRNA
in disease as biomarkers to aid in treatment decisions. In the future, ncRNAs may even
become therapeutic targets for RNAi to prevent ncRNAs from silencing tumor supressors or
operating to exacerbate disease states (reviewed in [59]).
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1.4 SRG1/SER3 AS A MODEL FOR REGULATION BY NCRNA
TRANSCRIPTION
Previous studies have discovered a noncoding DNA (ncDNA) sequence, SRG1 (SER3
Regulatory Gene 1), that is transcribed across the promoter of the adjacent downstream
gene, SER3, resulting in SER3 repression [45]. Based on the prevalence of transcription
that occurs in proximity to promoters of protein-coding genes, this mechanism serves as a
general model for gene regulation by intergenic transcription. SER3 encodes an enzyme that
catalyzes a step in the serine biosynthesis pathway [1] and its expression is tightly regulated
by the availability of serine [46]. Transcription of SRG1 serves as the regulatory switch that
responds to serine availability [46]. This is a complex regulatory system involving many
factors including the Spt6 and Spt16 histone chaperones, Paf1 elongation complex, and their
control of chromatin [22, 60, 21].
In high serine conditions, the Cha4 activator protein recruits the SAGA HAT and the
Swi/Snf chromatin remodeling complex to initiate RNA pol II transcription of SRG1 (Figure
1.3). As RNA pol II transcribes SRG1 through the SER3 promoter sequence, nucleosomes
are removed in front of the elongating RNA pol II and redeposited behind it in a man-
ner dependent on histone chaperones Stp6 and Spt16. The presence of these nucleosomes
block transcription factors from binding to the SER3 promoter [24]. When serine levels
become low in the cell, Cha4 no longer associates with SAGA and Swi/Snf, resulting in
the loss of SRG1 transcription-coupled nucleosome remodeling across the SER3 activating
sequence. This provides transcription factor access to the SER3 promoter [46, 24]. Two po-
sitioned nucleosomes remain at the 5’ end of SRG1 during times of high serine when SER3
is expressed, which may be the source of histones that regulate SER3 expression through
promoter occlusion in a transcription dependent manner [24]. From these and other studies,
nucleosome occlusion of protein coding promoters in a manner dependent on transcription
of the ncDNA represents a novel mechanism of gene regulation. These studies provide a
framework for investigating new cases of gene regulation by ncDNA transcription.
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Figure 1.3: Model for regulation of SER3 by transcription of the ncDNA SRG1.
(A) A model for repression of SER3 by SRG1 transcription. In high serine conditions,
nucleosomes are remodeled and maintained over the SER3 promoter by SRG1 transcription.
These transiently positioned nucleosomes prevent the binding of an activator, leaving SER3
in a repressed state. The cell responds to serine starvation by turning off SRG1 transcription,
leading to a loss of the nucleosomes across the promoter, allowing activator binding and SER3
expression. (B) Northern blot analysis examining the effects of serine on the expression of
SRG1 and SER3. Cells were grown to a density of 1-2 X 107 cells/ml at 30◦C in SC+serine
media and shifted to SC-serine media for 25 min. SCR1 serves as a loading control.
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1.5 IDENTIFICATION OF PIR3 FOR REGULATION BY NCRNA
TRANSCRIPTION
The pervasiveness of non-coding transcription throughout eukaryotic genomes and the in-
creasing number of regulatory roles being found for ncRNAs suggest the possibility that
the act of transcription and/or RNA products may regulate a large number of protein
coding genes. To discover candidate ncRNAs that may have regulatory roles, we filtered
genome-wide RNA pol II microarray data (J. Martens, unpublished genome-wide data) to
find intergenic regions displaying high RNA pol II density across promoters of annotated
protein-coding genes. PIR3 was selected based on the presence of significant RNA pol II
occupancy over its promoter, indicating that intergenic ncRNA transcription could have a
regulatory role at the promoter (Figure 1.4). Previous studies have identified PIR3 as a gene
that encodes the cell wall protein (CWP) Pir3, part of the Pir (proteins with internal repeats)
family. These proteins were first identified based upon their N-terminal amino acid repeats
(18-19 residues, tandemly repeated 7-10 time in the case of Pir1, Pir2, and Pir3), and were
found to be non-essential [73]. A subsequent study aimed at systemically identifying cell
wall components, discovered the Pir family of proteins to be covalently linked, non-soluble,
major cell wall stability proteins. The alias given to these proteins is Ccw (covalently linked
cell wall proteins), with PIR3 designated as Ccw8 [51]. Clues as to how PIR3 expression
may be physiologically regulated by intergenic transcription could come from understanding
the role that Pir3 plays in cell wall construction and stability.
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Figure 1.4: Identification of intergenic transcription at PIR3 . Genome-wide RNA
pol II ChIP reveals high levels of Pol II binding upstream of PIR3, indicative of potential
intergenic transcription (Joe Martens, unpublished).
1.6 ROLE OF PIR3 PROTEIN IN CELL WALL
The yeast cell wall, of which the Pir3 protein is a part, is a complex and adaptable structure
with important functions including maintaining turgor pressure and cell shape, acting as
a protein scaffold, and protecting the cell against physical stress (reviewed in [42]) (Figure
1.5). Load-bearing β-1,3 and 1,6-glucans make up the inner layer of the cell wall and serve
as a scaffold for an outer layer of mannoproteins. Some chitin chains, accounting for a small
percentage of the total cell wall, are found glycosidically attached to the β-1,3-glucans with
attachment of chitin to β-1,3 and 1,6-glucans increasing in response to cell wall stress. The
flexible and helical shape of the β-1,3-glucans allow for cell wall flexibility, necessary for
remodeling during growth, mating, and response to cell wall stress. The β-1,6-glucans are
highly branched and are found external to the β-1,3-glucans, linked through an unknown
mechanism (reviewed in [35, 42]).
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Figure 1.5: Representation of the yeast cell wall. External to the lipid cell membrane,
β-1,3 and 1,6-glucans make up the inner layer of the cell wall. External to the glucan network,
glycproteins, such as mannoproteins, are linked to the β-1,6-glucans through modified GPIr
anchors, protecting the cell wall by reducing permeability. Cell wall protein (CWPs), like
Pir3, are covalently attached to β-1,3-glucans. Chitin (yellow diamonds) chains are found
predominately attached to β-1,3-glucans during normal cell growth.
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1.6.1 Protein components of the cell wall
Outer layer CWPs, decrease cell wall permeability, leading to protection against cell wall
perturbing agents (reviewed in[35]). Other CWPs are found directly attached to the the
β-1,3-glucan network through an alkali soluble linkage. This protein group is composed of
the Pir-CWPs with specific linkage occurring between the repetitive and conserved amino
acid motif and the β-1,3-glucans. No enzyme has been found to catalyze covalent linkage,
but an autocatalytic reaction has been suggested [17]. Evidence to support the involvement
of these CWPs in increasing cell wall strength comes from the fact that their expression is
increased in response to cell wall stress [6, 19]. Additionally, loss of multiple Pir proteins
leads to increased susceptibility to cell wall stress agents (reviewed in [42]).
1.6.2 Cell wall stress
Cell wall stress arising from environmental pressures or structural changes during normal cell
growth is addressed through the cell wall integrity (CWI) pathway (reviewed in [42]) (Figure
1.6). Two sub-families of plasma-membrane spanning sensors are responsible for initiating
CWI signaling. One group consists of the Wsc-type sensors encompassing Wsc1, Wsc2 and
Wsc3, and the other group includes Mid2 (Mating Induced Death) and Mtl1 (Mid-two-like
protein). It is believed the cell wall contacts of these transmembrane proteins are altered
as a result of cell wall perturbations, implicating them in the role of mechanosensors, rather
than molecule sensing proteins (reviewed in [29]).
Wsc1 and Mid2 interact with the guanosine nucleotide exchange factors (GEFs), Rom1
and Rom2. These GEFs can simultaneously interact with Rho1 to catalyze nucleotide ex-
change. Rho1 is an essential protein and a member of the (Ras-homologous) family of
GTPases that are integral to mediating polarized cell growth in mammalian and fungal
cells. The GTP-bound Rho1 can interact with and activate Pkc1 (protein kinase C), initi-
ating the linear Pkc1-activating MAPK (Mitogen Activated Protein Kinase) cascade. Pkc1
has been shown to phosphorylate Bck1 MEKK, which in turn phosphorylates the Mkk1/2
MEKs. Mkk1 and -2 phosphorylate the Mpk1/Slt2 MAPK [42]. Mpk1 activates the Rlm1
(resistant to the lethality of constitutive Mkk1) transcription factor through phosphorylation
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of its transcriptional activation domain (reviewed in [42]) [31]. It has been demonstrated
that Rlm1 is an important activator of at least 25 genes involved in cell wall biogenesis
[31]. Rlm1 contains an N-terminal binding domain with specificity for [CTA(T/A)4TAG]
conserved sequence. In particular, PIR3 possesses a canonical binding site for the Rlm1
transcription factor which may be important for PIR3 expression in cell wall stress-inducing
conditions [19, 30].
Figure 1.6: Schematic representation of the CWI MAPK pathway for Rlm1 ac-
tivation. Signaling is initiated by surface receptors, Mid2 or Wsc1, that interact with
GEFs Rom1 or Rom2, stimulating nucleotide exchange on Rho1. Activated Rho1 phospho-
rylates Pkc1, initiating the Pkc1-activated MAPK cascade. The Rlm1 transcription factor
is phophorylated at the completion of cascade and activates expression of genes important
in cell wall biogenesis.
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1.7 PIR3 REGULATION IN RESPONSE TO CELL WALL STRESS
As previously mentioned, the CWI pathway is upregulated in response to cell wall stress from
a variety of sources. Through genome-wide analysis assessing the transcriptional response
to cell wall stress agents and cell wall mutations, PIR3 has demonstrated increased mRNA
expression, presumably through Slt2 mediated activation of the Rlm1 transcription factor
[6, 39, 19]. PIR3 has been shown to be induced upon over-expression of Mkk1, also a part
of the MAPK kinase pathway that activates Rlm1, in response to prolonged elevations in
temperature (39◦C) [30]. Additionally, pir3 deletions, particularly when combined with other
deletion of the Pir family proteins, leads to increased sensitivity to osmotin (plant antifungal
protein), congo red (β-1,3-glucan-binding) calcoflour white (chitin antagonist), and caffeine
(activator of Pkc1-MAPK kinase cascade) [83, 52, 71, 49]. Rlm1 has been demonstrated
to be an important factor in activating genes associated with caffeine-induced stress [76].
Evidence suggests that this protective effect may be the result of multiple β-1,3-glucans
linking to the internal amino acid repeats of the Pir proteins, decreasing the permeability of
the cell wall to these agents [35]. Although much remains to be discovered about the role of
PIR3 in inducing cell wall strength and stability, we can use these studies to assist in our
analysis of regulation by ncRNA. Particularly, growing cells in conditions that induce cell
wall stress with subsequent analysis of expression of the ncRNA and PIR3 ORF may lead to
identification of natural conditions in which intergenic transcription plays a regulatory role.
From this investigation I am able to demonstrate a new source for repression by intergenic
transciption at PIR3.
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2.0 THESIS AIMS
Accumulating evidence is implicating ncRNAs in gene regulation, rather than as transcrip-
tional by-products. However, many sources of ncRNA transcription have been identified
without implication in defined regulatory roles. I began this investigation with the hypoth-
esis that intergenic noncoding RNA across the PIR3 promoter enacts a regulatory function.
This hypothesis is supported by studies at SRG1/SER3 where nucleosome deposition across
the SER3 promoter occurs in a manner dependent on transcription of the intergenic ncRNA
SRG1. My goal in this study was to provide evidence supporting regulation of PIR3 expres-
sion by intergenic transcription. Here, I provide evidence that PIR3 expression is in fact
affected by intergenic transcription. This regulation appears to be occurring in a manner
independent of the Rlm1-mediated cell wall stress response. Although my studies into the
mechanism of regulation at PIR3 are not complete, my data suggest that PIR3 repression
by intergenic transcription occurs by a mechanism that is distinct from what we have previ-
ously described for SER3.
Specific Aim #1: Analyze ncRNA transcription upstream of PIR3.
The goal of this Aim is to determine if intergenic transcription upstream of PIR3 has a
regulatory function. Following verification of ncRNA, a method for inserting a strong tran-
scription termination sequence within the region of intergenic transcription was employed to
stop intergenic transcription across the PIR3 promoter. The affect that loss of the ncRNA
has on PIR3 expression was investigated.
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Specific Aim #2: Determine the start site PIR3 ncRNA.
The goal of this Aim is to map start sites for the intergenic and PIR3 transcripts. This will
help to characterize the ncRNA and PIR3 in terms of start site of transcription initiation.
Specific Aim #3: Determine a model for regulation at PIR3.
Regulation of gene expression by intergenic transcription could occur by a number of mech-
anisms, including the ncRNA product in trans or promoter occlusion in cis. Promoter
occlusion in cis could occur through nucleosome remodeling at the promoter or through re-
pressive post-translational histone modifications. The transcription interference mechanism
regulates gene expression by blocking access of activators or transcription factors to the gene
promoter through the act of transcription. There are three goals of this Aim:
1) Determine if the intergenic ncRNA at PIR3 regulates in cis or in trans.
2) Test the role of chromatin in PIR3 regulation.
3) Determine if transcription interference is working at PIR3 by assessing TBP occupancy
at the PIR3 promoter in the absence or presence of intergenic transcription.
Specific Aim #4: Determine if regulation by intergenic transcription has a
physiological basis in cell wall stress.
Previous studies have implicated PIR3 expression to increase in response to cell wall stress in
an manner dependent on the Rlm1 transcription activator. Some of these inducing conditions
include caffeine and prolonged temperature increases, which can activate the CWI pathway.
The goal of this Aim is to determine if these conditions may activate PIR3 through loss of
intergenic transcription, implicating the ncRNA transcription in interfering with Rlm1 bind-
ing in none-stress conditions. This hypothesis will be tested by growing cells and measuring
the levels of ncRNA and PIR3 mRNA at elevated temperatures as well as in caffeine in order
to determine if regulation by the PIR3 ncRNA has a basis in CWI signaling [76, 30, 32].
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3.0 MATERIALS AND METHODS
3.1 YEAST STRAINS AND MEDIA
Saccharomyces cerevisae strains are derived from a GAL2+ strain of S288C and are listed
in Table 3.1 [79]. All strains were constructed using standard transformation techniques
and genetic crosses [2]. Strains were grown in the following media as indicated in the figure
legends: YPD (1% yeast extract, 2% peptone, 2% glucose), YPD + caffeine (1% yeast
extract, 2% peptone, 2% glucose, 12mM caffeine) [65].
The pir3TTS allele was created to terminate transcription of the PIR3 ncRNA by insertion
of a 171bp DNA fragment containing a minimal HIS3 transcription termination sequences,
HIS3 -TTS (Figure 4.3). The pir3TTS allele was constructed by PCR-mediated two-step gene
integration as has been previously described [65]. First, a 1276bp sequence containing URA3
flanked by 171bp of the HIS3 termination sequence was amplified from pDW1 (unpublished
Danielle Wagner) using a pair of primers, each having 60bp of sequence on their 5 ends
derived from the sense and antisense strands on either side of the site of integration into
the genome. Ura+ transformants were passaged on non-selective media (YPD). Following
overnight growth at 30◦C, they were replica-plated onto media containing 5-Fluoroorotic acid
(5-FOA) (1mg/µl, US Biological), a drug that is toxic to Ura+ yeast cells, to select for cells
that have lost the URA3 gene by homologous recombination leaving behind a single copy of
the HIS3 -TTS. Correct insertion of the HIS3 -TTS at -486bp relative to the translation start
of PIR3 was verified by PCR. The srg1TTS was created in the same manner with placement
of the HIS3 -TTS at -450bp, relative to SER3 ATG. The ura3TTS allele was generated from
the pir3TTS allele with replacement of the PIR3 ORF (from +1 to +977; PIR3 ATG=+1)
with a PCR-generated URA3 ORF (from +1 to +804bp; URA3 ATG=+1).
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Strains containing the histone H3 K122A double mutation were created by a one-step
integration of plasmids expressing a synthetic histone gene targeting the HHT1/HHF1 locus
and tagged with a selectable hygromycin resistant cassette (kind gift from J. Dai, Tsinghua
University). The strains used in this transformation were JDY86 strains expressing another
H3 K122A synthetic histone gene sequence replacing HHT2/HHF2 marked by a selectable
URA3 marker. Both histone mutations, at HHT2/HHF2 and HHT1/HHF1, were created as
part of a plasmid library of histone H3 and H4 mutants containing a number of systematic
amino acid substitutions (previously described [14]). The plasmids containing these muta-
tions can be integrated into the yeast genome through homologous recombination between
sequences flanking the selectable marker and mutation on the plasmid and the genomic site
of the H3/H4 genes. Plasmids were linearized with BciVI and transformed into the JDY86
strain with the (hht2-hhf2)∆::hhts-K122A/HHTS-URA3 mutation by homologous recombi-
nation (previously described [14]). Transformants were selected on YPD media containing
200µg/mL of hygromycin, and confirmed through PCR and sequencing (unpublished, S.
Hainer).
pir3-nctata1, pir3-nctata2, pir3-nctata3 (pir3 noncoding tata) alleles were generated by
two-step gene replacement as previously described [65]. Putative PIR3 ncRNA TATA ele-
ments (Figure 4.1) were mutated to a Avr II restriction site by tranformation with integrating
URA3 -marked plasmids pRM13, pRM14, pRM15 (see description below) into ura3∆ strains,
that had been linearized with EcoRI. Transformants were selected for on plates containing
SC-URA. Ura+ transformants were passaged on non-selective media (YPD) and then repl-
icaplated onto media containing 5-FOA to select for strains that have lost the integrating
sequence by homologous recombination. Replacement of the TATA elements with Avr II was
verified by PCR and subsequent restriction digest.
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3.2 PLASMID CONSTRUCTION AND ANALYSIS
Plasmids were constructed and isolated from Escherichia coli by standard methods
[2].
pDW1 was created by three successive cloning steps (D. Wagner). First, one copy of
the HIS3 -TTS sequence with flanking NotI restrcition sites was PCR-generated from ge-
nomic DNA. The NotI restriction sites were used to ligate HIS3 -TTS into the polylinker of
pBluescript II SK- (Stragene). Correct orientation of inserts was tested by restriction digest.
URA3 was excised from pRS406 and ligated into the same pBluescript II SK- using the
EcoRI and XbaI restriction sites. A second copy of the HIS3 -TTS sequence with flanking
EcoRI and XhoI restriction sites was PCR-generated from genomic DNA and ligated into
a separate pBluescript II SK-. This EcoRI-HIS3TTS-XhoI fragment was then cut and lig-
ated into the NotI-HIS3TTS-NotI containing plasmid. The resulting pDW1 contains URA3
flanked by copies of HIS3 -TTS sequences (Figure 4.3)
An EcoRI to BamHI DNA fragment containing the PIR3 sequence from -1319 to -
225 (PIR3 ATG=+1) that was generated by PCR and cloned into pBluescript II SK- to
generate pRM04. This sequences contains putative ncRNA TATA elements, sites 1, 2, and
3 (Figure 4.1) that may promote PIR3 ncRNA transcription. Each site was mutated to
an Avr II site (CCTAGG) by Quick-Change Mutagenesis on three separate plasmids [84].
pRM06 contains the site 1 Avr II mutation (from -682 to -677; PIR3 ATG=+1); pRM09
contains the site 2 Avr II mutation (from -765 to -760; PIR3 ATG=+1); pRM10 contains
the site 3 Avr II mutation (-870 to -865; PIR3 ATG=+1). Adaptations to the standard site-
directed mutagenesis protocol included use of phusion polymerase with the 5X high fidelity
(HF) mix (Fermentas), 0.15µl of each 100µM primer, 10-50ng plasmid template, and 1.0µl
of a mix containing 10mM of each dNTP, for a total reaction volume of 50µl. The PCR
conditions were 98◦C for 10 sec; 20 cycles of 98◦C for 30 sec, 55◦C for 30 sec and 72◦C for
7 min, for a ∼4Kb plasmid, with annealing temperatures adjusted based on primer melting
temperature. Following DpnI digestion, 5µl of each reaction was transformed into DH5α cells
using standard methods and selected for on LuriaBertani (LB) plate containing 100µg/ml
ampicillin. Following confirmation by sequencing, the mutated fragments were sublconed by
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excision from pBluescript II SK- and ligation into individual integrating plasmids pRS406
[12] using EcoRI and BamHI restriction enzymes resulting in pRM13, pRM14, and pRM15,
containing pir3-nctata1, pir3-nctata2, pir3-nctata3, respectively. pSPT16-URA, pSPT16-
LEU2, and pspt16-E857K-LEU2 have been previously described [21].
Table 3.1: Yeast Strains
Strains Genotype Source
FY4 MATa F. Winston
FY2431 MATa his3∆200 lys1-128δ leu2∆1 spt2∆0 F. Winston
KY719 MATa ura3∆0 K. Arndt
KY912 MATa hhis3∆200 leu2∆1 lys2-128δ ura3-52
set2∆::HIS3
K. Arndt
KY934 MATα his3∆200 leu2∆1 trp1∆63 dot1∆::HIS3 K. Arndt
KY938 MATα his3∆200 leu2∆1 trp1∆63 set1∆::HIS3 K. Arndt
KY1235 MATa his3∆200 lys2-128δ ura3-52 rco1∆::HIS3 K. Arndt
KY1703 MATa rtf1::KanMX rtf1∆::kanMX4 K. Arndt
JD86 MATa his3∆200 leu2∆0 lys2∆0 trp1∆63 ura3∆0
met15∆0 (hht1-hhf)∆::NatMX4 (hht2-
hhf2)∆::HHTS/HHFS (or containing substitution)-
URA3 can1∆::MFApr-HIS3
[14]
YJ785 MATa paf1∆::kanMX4 K. Petrov
YJ787 MATα rtf1∆::kanMX4 K. Petrov
YJ788 MATα his3∆200 rtf11∆::kanMX4 K. Petrov
YJ807 MATα his3∆200 paf1∆::kanMX4 K. Petrov
YJ809 MATα ura3∆0 paf1∆::kanMX4 K. Petrov
YJ822 MATa srg1::srg1TTS D. Wagner
YJ1091 MATα ura3∆0 leu2∆0 his4-912δ lys2-128δ trp1∆63
spt16∆::KanMX pSTP16-URA3
[21]
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Table 3.1: Yeast Strains (continued)
Strains Genotype Source
YJ1092 MATa ura3∆0 leu2∆0 his3∆200 spt16∆::KanMX
KanMX-Gal1-prFLO8-HIS3 pSPT16-URA3
[21]
YJ1100 MATa pir3::pir3TTS This study
YJ1101 MATa pir3::pir3TTS This study
YJ1102 MATa pir3::pir3TTS This study
YJ1103 MATa his3∆200 leu2∆0 lys2∆0 trp1∆63 ura3∆0
met15∆0 (hht1-hhf1)∆::HHTS-HHFS -Hygro (hht2-
hhf2)∆::HHTS-HHFS-URA3 can1∆::MFApr-HIS3
S. Hainer
YJ1104 MATa his3∆200 leu2∆0 lys2∆0 trp1∆63 ura3∆0
met15∆0 (hht1-hhf1)∆::HHTS-HHFS -Hygro (hht2-
hhf2)∆::HHTS-HHFS-URA3 can1∆::MFApr-HIS3
S. Hainer
YJ1105 MATa his3∆200 leu2∆0 lys2∆0 trp1∆63 ura3∆0
met15∆0 (hht1-hhf1)∆::HHTS-HHFS -Hygro (hht2-
hhf2)∆::HHTS-HHFS-URA3 can1∆::MFApr-HIS3
S. Hainer
YJ1106 MATa his3∆200 leu2∆0 lys2∆0 trp1∆63 ura3∆0
met15∆0 (hht1-hhf1)∆::hhts-K122A/HHFS -
Hygro (hht2-hhf2)∆::hhts-K122A/HHTS-URA3
can1∆::MFApr-HIS3
S. Hainer
YJ1107 MATa his3∆200 leu2∆0 lys2∆0 trp1∆63 ura3∆0
met15∆0 (hht1-hhf1)∆::hhts-K122A/HHFS -
Hygro (hht2-hhf2)∆::hhts-K122A/HHTS-URA3
can1∆::MFApr-HIS3
S. Hainer
YJ1108 MATa his3∆200 leu2∆0 lys2∆0 trp1∆63 ura3∆0
met15∆0 (hht1-hhf1)∆::hhts-K122A/HHFS -
Hygro (hht2-hhf2)∆::hhts-K122A/HHTS-URA3
can1∆::MFApr-HIS3
S. Hainer
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Table 3.1: Yeast Strains (continued)
Strains Genotype Source
YJ1109 MATa/MATα ura3∆0/ura3∆0
pir3∆::ura3TTS/PIR3
This study
YJ1110 MATa/MATα ura3∆0/ura3∆0
pir3∆::ura3TTS/PIR3
This study
YJ1111 MATa/MATα ura3∆0/ura3∆0
pir3∆::ura3TTS/PIR3
This study
YJ1112 MATa/MATα ura3∆0/ura3∆0
pir3∆::URA3/pir3::pir3TTS
This study
YJ1113 MATa/MATα ura3∆0/ura3∆0
pir3∆::URA3/pir3::pir3TTS
This study
YJ1114 MATa/MATα ura3∆0/ura3∆0
pir3∆::URA3/pir3::pir3TTS
This study
YJ1115 MATa ura3∆0 This study
YJ1116 MATa ura3∆0 This study
YJ1117 MATa/MATα This study
YJ1118 MATa/MATα This study
YJ1119 MATa/MATα This study
3.3 NORTHERN ANALYSIS
Cells were grown in the media as indicated in figure legend to mid-log (1-2 X 107 cells/ml) at
30◦C. Total RNA isolation and Northern blot analysis was performed as previously described
[2]. Double-stranded DNA probes were radiolabled with [α-32P] dATP by random-primed
labeling of purified PCR fragments. Location of probes are relative to the ATG=+1 of
each gene and are as follows: SER3 (+111 to +1342; OJ63 & OJ64), SRG1 (-454 to -123,
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relative to SER3 ATG), SCR1 (+163 to +284, relative to SCR1 ATG), PIR3 (-479 to -101;
OJ1334 & OJ1335 and +501 to +709; OJ1465 & OJ1467) URA3 (+261 to +690; OJ1388 &
OJ1389). Phosphorimages were obtained on a GE Typhoon FLA 7000 and analyzed using
the ImageJ software package.
3.4 CHROMATIN IMMUNOPRECIPITATION (CHIP)
Cells were grown in YPD at 30◦C to a density of 1-2x107 cells/ml and then treated with
1% formaldehyde for 20 min. Chromatin was isolated and sonicated as previously described
[69] and then incubated with antibodies overnight at 4◦C, while rotating. 2µl anti-TBP
was used to immunoprecipitate TBP. Primary antibody-protein conjugates were isolated by
incubating with 30µl Protein A-coupled Sepharose beads (GE Healthcare) at 4◦C for 2 to
3 hr. After purifying DNA through PCR purification columns (Qiagen), the amount of
immunoprecipitated (IP) DNA relative to input DNA was determined by quantitative PCR
(qPCR) by normalizing to a template located within a region of chromosome V that lacks
ORFs (No ORF) [36].
3.5 REAL-TIME QPCR
ChIP assays were analyzed by qPRC using an ABI StepOnePlus real-time PCR machine
and SYBR green (Fermentas). Quantitation of real-time PCR results were calculated based
on comparative ∆CT using the Pfaffl method which takes into account variations in primer
efficiency while normalizing to a standard control (No ORF) [55]. Primer set locations are
relative to the translation start of PIR3 ATG=+1 and include the following: Internal to
the PIR3 ORF (+548 to +644; OJ1652 & OJ1653), targeting the putative PIR3 TATA box
(-214 to -117; OJ1654 & OJ1655), targeting the putative PIR3 ncRNA TATA site 1 (-713
to -634; OJ1656 & OJ1657), targeting the putative PIR3 ncRNA TATA site 3 (-893 to -791;
OJ1658 & OJ1659), No ORF (OJ477 & OJ478) (previously described in [36]).
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3.6 PRIMER EXTENSION
Primer extension reactions were performed on 20µg of total RNA. Protocols followed were
based on previously described methods [64]. The oligo labeling reaction was performed with
4µl of 50 ng/µl purified oligo and 6000µci/µl γ 32P. The primer extension reaction was
carried out with 5 X 106 CPMs of radioactively labeled oligo and the sequencing reaction
was performed with 5 X 105 CPMs of radioactively labeled oligo using the USB sequencing
kit, Sequenase version 2.0. Oligo positions are relative to the translation start of PIR3 and
are as follows: PIR3 -o2 (+12 to +35; OJ1367), PIR3 -i7 (-620 to -600; OJ1486). The ADH1
control primer (OJ1371) corresponds to bases +32 to +10 of the ADH1 -coding sequence as
previously described [45]. Phosphorimages were obtained on a GE Typhoon FLA 7000.
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4.0 RESULTS
4.1 MAP OF THE PIR3 LOCUS
PIR3 was chosen as a candidate gene for regulation by ncRNA due to the presence of
significant RNA polymerase II occupancy over its promoter based on previous genome-wide
RNA pol II ChIP data (Figure 1.4). Throughout this study, I have gathered information on
expression data and regulatory sequences at the PIR3 locus. In figure 4.1, I have summarized
the details of this information. All sites indicated by base pair position are relative to the
PIR3 ATG at +1bp of the 978bp coding sequence. Regulatory elements are based on
consensus sequence alignment or published genome-wide analysis. For example, a potential
TATA box for the PIR3 ORF was identified at -145bp by consensus sequence alignment
that I performed. Approximately 100bp upstream of this TATA site at -251bp, a sequence
was identified as a consensus recognition site for the Rlm1 transcription activator based on
a genome-wide study assessing the effects on gene expression in response to activation of
the MAP kinase, Mpk1/Slt2 [30]. Transcriptome analysis surveying transcript structure and
expression levels across the yeast genome as well as a study mapping transcription boundaries
by RNA-Seq, identified the same 5’ end for the PIR3 mRNA at -250bp, indicated by the
arrow directly downstream of the Rlm1 binding site [80, 53]. Additional elements identified
from genome-wide studies include putative TATA sites for the intergenic ncRNA discovered
from Chip-exo data aimed at identifying sites of PIC assembly (red rectangles site 1 and
site 3) [63]. The light red rectangle at site 2 also represents a putative intergenic TATA
element, which was determined by consensus sequence alignment. In our lab, transcription
start sites (TSS) for the intergenic transcript were mapped by 5’ RACE and are indicated by
the green pentagons (Rapid Amplification of cDNA Ends) (unpublished, Danielle Wagner).
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Two sites were identified in repeat RACE experiments at -610bp and -810bp. Transcriptome
data was also a source for identifying annotated noncoding RNAs that may be important
at PIR3 [80]. This search led to the identification of SUT228, which is estimated to be
1.1Kb long. It appears to initiate at -1.218Kb and extend to -82bp upstream of the PIR3
ATG. Given that SUT228 is transcribed within the intergenic region of PIR3, it would seem
to be a likely candidate for regulation by ncRNA. However, when we attempted to disrupt
intergenic transcription (details below and in Materials and Methods) near the mapped
TSS at -810bp, a transcript signal was still visible by Northern analysis (data not shown).
If SUT228 were transcribing across this region, we would have expected to see a loss of
transcription. In addition, the predicted start site for SUT228 is much farther upstream
of either TSS mapped by 5’ RACE, and the 600bp ncRNA that I have predicted from my
Northerns is about half the size predicted for SUT228. Consistent with these observations,
insertion of the TTS at -486bp (purple diamond) was successful in terminating intergenic
transcription, which will be expanded upon later in the results section.
4.2 IDENTIFICATION OF INTERGENIC TRANSCRIPTION AT PIR3
The genome-wide RNA pol II data provided strong evidence for intergenic transcription over-
lapping the PIR3 promoter (Figure 1.4). In order to confirm this data, Nothern analysis
was performed. Using a probe 5’ of PIR3, we detected an intergenic transcript of approxi-
mately 600bp in length. Reprobing this Northern using a probe contained within the PIR3
coding sequence, detected the PIR3 mRNA with an estimated size of 1.2Kb (Figure 4.1).
This result supports the RNA poI II ChIP data that intergenic transcription is occurring
upstream of PIR3.
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Figure 4.1: Map of the PIR3 locus. The PIR3 locus is mapped with estimated sizes and
locations of the ncRNA and ORF transcripts. Sizes were estimated from Northern analysis
by comparison to a standard RNA ladder. Important elements are noted such as the Rlm1
conserved DNA binding sequence [30]. 5’ RACE mapped transcription start sites (green
pentagons) and putative regulatory elements determined from genome-wide Chip-exo data
[63] (red rectangles) and sequence alignment (light red rectangles). A putative transcription
start site for PIR3 mRNA is indicated by the arrow in between the Rlm1 binding site and
the TATA box. The purple diamond indicated the location of the TTS that disrupts ncRNA
transcription.
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Figure 4.2: Northern analysis validating PIR3 ncRNA and PIR3 transcript. Rep-
resentative Northern analysis of three independent experiments to confirm the presence of
intergenic transcription based on the genome-wide RNA pol II ChIP data. Below the North-
ern blot, a diagram of a PIR3 locus indicates the approximate locations of Northern probes.
Total RNA was isolated from the wild type KY719 strain grown to a density of 1-2 X 107
cells/ml in YPD at 30◦C. SCR1 is used as a loading control.
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4.3 DEVELOPMENT OF TRANSCRIPTION TERMINATION STRATEGY
TO PREVENT INTERGENIC TRANSCRIPTION
In order to determine if intergenic transcription affects PIR3 mRNA levels, I needed a
method to stop intergenic transcription. When I began this study, potential regulatory
sequences for the PIR3 ncRNA were not defined, making disruption of transcription by
mutation difficult. Therefore, a strategy was developed to utilize a strong transcription
termination sequence from the HIS3 gene (HIS3 -TTS) to prematurely terminate the PIR3
ncRNA. Briefly, a plasmid, pDW1, containing a construct of tandem copies of the HIS3 -
TTS, consisting of 171bp from the 3’ end of HIS3, flanking the URA3 gene as a selectable
marker was generated (D. Wagner, unpublished). In order to target a particular genomic site
for disruption of transcription, this construct can be PCR-amplified using primers that bear
homologous sequence to the genomic integration site for transformation into yeast. After
selection, the URA3 gene can be lost by homologous recombination between the two copies
of the TTS, yielding a strain with one copy of the TTS at the desired location (Figure 4.3).
The desired result will be premature termination of the intergenic transcription without any
alteration of regulatory elements. Using this method I constructed the pir3TTS in addition
to the already constructed srg1TTS allele (D. Wagner) (see Materials and Methods for more
details).
In order to test the efficacy of this strategy, I first assessed the effects of TTS insertion
on repression of SER3 by SRG1. A transformation was performed for insertion of the HIS3 -
TTS at -450bp, relative to the SER3 ATG. The srg1TTS and wild type control strains were
grown in serine-rich media (rich media, YPD). Normally in high serine conditions, SRG1 is
transcribed, resulting in strong repression of SER3. This result is in fact replicated in the
wild type strain (Figure 4.3, panel C, first lane). In contrast, SRG1 transcript signal is lost
in srg1TTS strain, and SER3 mRNA levels are strongly increased, reproducing the results
observed when the SRG1 TATA box is mutated and nonfunctional (Figure 4.3, panel C,
second lane). These results indicate that insertion of the HIS3 -TTS is a practical method
for disrupting transcription in lieu of promoter mutations.
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Figure 4.3: A strategy for disrupting intergenic transcription.
The TTS sequence is derived from the terminal 171bp of the HIS3 gene. (A) Diagram of
the pDW1 plasmid used as the PCR template for the selectable URA3 gene flanked by the
HIS3 -TTS. (B) Outline for integration of the HIS3 -TTS into the yeast genome. (C)
Northern analysis for control experiment using SRG1/SER3. Yeast strain YJ822 (srg1TTS)
and KY719 (wild type) were grown in rich media (YPD) at 30◦C to a density of 1-2 X 107
cells/ml. SCR1 serves as a loading control.
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4.4 LOSS OF NCRNA LEADS TO AN INCREASE IN PIR3 EXPRESSION
Having successfully developed a method for disruption of intergenic transcription, I assessed
the effect of PIR3 ncRNA on transcription of PIR3. In order to determine a target site
for insertion of the HIS3 -TTS within the sequence of the PIR3 ncRNA, the transcription
start sites for the PIR3 ncRNA were determined by 5’ RACE, as previously described
(Figure 4.1). The start site farthest upstream (-810bp) of the PIR3 ATG was initially
targeted for disruption; however, insertion of the TTS at -800bp did not result in loss of
intergenic transcript (data not shown). Therefore, I inserted the TTS at -486bp, 3’ of a
second transcription start site, mapped at -610bp, generating the pir3TTS allele. Wild type
and pir3TTS strains were grown in rich media and transcript expression was tested by Northern
analysis. For the wild type strains, the Northern results displayed the expected signal for the
PIR3 ncRNA and ORF transcripts (Figure 4.4, panel A, lane 1). Interestingly, insertion of
the TTS successfully terminated the intergenic transcript, and resulted in a 2-fold increase in
PIR3 expression (Figure 4.4, panel A, lane 2). These results support a potential regulatory
mechanism whereby the loss of ncRNA leads to an increase in PIR3 expression, indicative
of a repressive function for intergenic transcription.
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Figure 4.4: Termination of intergenic transcription at PIR3 results in increased
PIR3 expression. (A) Representative Northern analysis of three independent experiments
assessing the effect that loss of the ncRNA has on PIR3 expression. Start sites of ncRNA
at PIR3 were determined by 5’ RACE, directing placement of the HIS3 -TTS. Insertion of
HIS3 -TTS, results in loss of the ncRNA with a subsequent increase in expression of the
PIR3 ORF. (B) Quantitation of (A). PIR3 levels in the pir3TTS strains are normalized to
the SCR1 loading control and made relative to PIR3 levels of the wild type strain (arbitrarily
set to 1). Strains KY719 (wild type or WT), YJ1100, YJ1101, and YJ1102 (pir3TTS) were
grown in rich media (YPD) at 30◦C to a density of 1-2 X 107 cells/ml. SCR1 serves as a
loading control.
38
4.5 DETERMINATION OF TRANSCRIPTION START SITES (TSS) FOR
PIR3 NCRNA AND PIR3
To better characterize the ncRNA, I performed primer extension to map the 5’ ends of the
PIR3 ncRNA and PIR3 mRNA. Separate oligos were designed to target the 5’ ends of the
PIR3 ncRNA and PIR3 mRNA, using the 5’ RACE and genome-wide data to direct the
position of oligos most likely to map a TSS [80]. Oligo PIR3 -o2 was designed to target the
5’ end of the PIR3 mRNA and anneals from +35bp to +12bp of the PIR3 coding sequence.
Oligo PIR3 -i7 was designed to target the 5’ end of the PIR3 ncRNA and anneals from -600
to -620 upstream of the PIR3 ATG. In each primer extension analysis, I compared a wild
type to a pir3TTS strain. Primer extension at ADH1 results in two strong TSS signals. This
reaction was used as a positive control for quality of RNA samples and amount of RNA
loaded for each sample.
When using oligo PIR3 -o2, I would expect to see a TSS signal that is stronger in the
pir3TTS strain as compared to the wild type strain. This would support the Northern result
demonstrating the increase in PIR3 expression in the pir3TTS strain. Oligo PIR3 -o2 mapped
two starts sites at -38bp and -80bp upstream of the PIR3 ORF (Figure 4.5, panel B). In
comparing the wild type to the pir3TTS strain, I do see increased signal in the pir3TTS strain
at both locations. In mapping the PIR3 ncRNA, I would expect to see signal from both the
wild type and the pir3TTS strain. The start sites mapped by oligo PIR3 -i7 in the wild type
strains were at -718bp and -663bp (Figure 4.5 C). Both sites map 5’ of the putative TATA
elements and they are also near the -610bp TSS mapped by 5’ RACE, making them attractive
candidates for a TSS (Figure 4.1). However, I did not see the same signal intensity in the
pir3TTS strain. RNA degradation was likely the cause of this negative result, as the ADH1
control reaction for the pir3TTS strain displayed no signal. Overall, I identified putative
transcription start sites for both PIR3 ncRNAs and PIR3 mRNA; however, additional
analysis will be required to confirm these sites. Additional experiments will be required
to confirm these mapped sites.
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Figure 4.5: Determination of transcription start sites (TSS) for PIR3 ncRNA and
PIR3. (A) A diagram of the PIR3 locus highlighting the oligos used in primer extension.
The color of the oligo corresponds to the mapped start site marked by * of matching color.
(B and C) Primer extension analyses. Wild type strains were compared to pir3TTS strains.
Oligos are listed next to each gel. Oligo PIR3 -o2 mapped two start sites at -38bp and -80bp
PIR3. Oligo PIR3 -i7 mapped two start site at -718bp and -663bp for the PIR3 ncRNA. The
mapped start sites are highlighted in red. Primer extension at ADH1 displayed below each
image was used as a control to measure amount of RNA loaded and to assess RNA quality.
Strains KY719 (Wild type), YJ1100, YJ1101, YJ1102 (pir3TTS) were grown in rich media at
30◦C to a density of 1-2 X 107 cells/ml.
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4.6 PIR3 IS REPRESSED IN CIS BY INTERGENIC TRANSCRIPTION
After determining that loss of the PIR3 ncRNA leads to a 2.0-fold increase in PIR3 expres-
sion, I next wanted to determine a model for the mechanism of regulation. My hypothesis
was that intergenic transcription across the PIR3 promoter will produce a regulatory effect in
cis, as observed at the SRG1/SER3 locus, supporting the concept that the act of transcrip-
tion and not the ncRNA product represses PIR3. To test this, I used a previously described
cis/trans experiment (Martens et al., 2004). Briefly, I constructed diploid strains in which
one copy of the PIR3 -coding sequence was replaced by the sequence for URA3, allowing
expression from each PIR3 promoter to be assayed independently. Diploid 1 expressed the
ura3TTS allele where the PIR3 intergenic transcription will be terminated upstream of the
allele containing URA3 in place of PIR3, and Diploid 2 expressed the pir3TTS allele where
PIR3 intergenic transcription will be terminated upstream of the allele containing PIR3 (see
Materials and Methods for strain construction details).
Each diploid was grown in YPD and subjected to Northern analysis (Figure 4.6). In the
first two lanes of the Northern blot, the haploid wild type strain and the pir3TTS strain (lanes
1 and 2, respectively) again demonstrate the 2-fold increase in PIR3 ORF expression when
the intergenic transcript is disrupted. When comparing signals from diploid 1 and diploid 2,
wild type PIR3 ncRNA transcription represses the PIR3 promoter only when in cis ((Figure
4.6, lane 4, Diploid 2)). Additionally, repression of the URA3 was also observed, but only
when adjacent to the wild type PIR3 ncRNA (Figure 4.6, lane 3, Diploid 1). If the ncRNA
were working in trans we would have expected to see an equal level of expression in both
protein coding genes regardless of location of the TTS. These results show that the repressive
effect of intergenic trasncription on the PIR3 ORF occurs in cis. Although I cannot exclude
a possible role for the ncRNA in repression of PIR3, our data suggest that PIR3 is most
likely repressed by the act of intergenic transcription.
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Figure 4.6: Intergenic transcription repressesPIR3 in cis. (A) Diagram of the diploid
strains used in an assay to determine whether the intergenic transcript has a cis or trans
effect on the PIR3 ORF. Diploids were constructed in which a second copy of the PIR3 ORF
was replaced, in frame, by the URA3 ORF. Intergenic transcription is disrupted by insertion
of the TTS either upstream of URA3 (Diploid 1; ura3TTS allele) or upstream of PIR3 (Diploid
2; pir3TTS allele). (B) Representative Northern analysis of three independent experiments
depicting the results of the cis/trans test, which indicate repression in cis. Diploid 1 strains
YJ1109, YJ1110, YJ1111 and Diploid 2 strains YJ1112, YJ1113, and YJ1114 were grown
in rich media (YPD) at 30◦C to a density of 1-2 X 107 cells/ml. SCR1 serves as a loading
control
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4.7 EFFECT OF INTERGENIC TRANSCRIPTION ON TBP BINDING AT
THE PIR3 PROMOTER
Repression by intergenic transcription in cis could occur through a number of regulatory
mechanisms including promoter occlusion through transcription interference or altered chro-
matin structure. In the transcription interference model, transcription of PIR3 ncRNA
across the PIR3 promoter would prevent access of transcription factors or disrupt activator
binding. Occlusion of the yeast FLO11 promoter by upstream ncRNA results in repression
through blocked access of general transcription factors [9], whereas ADH1/ADH3 repression
occurs through ncRNA transcritption-mediated removal of bound activators [5]. In order
to test whether PIR3 ncRNA may be repressing PIR3 by denying access of transcription
factors, I performed ChIP and quantitative real-time PCR to assess occupancy of TBP, an
integral factor in promoter initiation complex (PIC) formation for transcription initiation.
Primers flanking a putative TATA sequence for PIR3 expression were used to assess
TBP binding at PIR3. A primer sets was designed to target the PIR3 consensus TATA
sequence (”ORF TATA”). (Figure 4.7). Low levels of TBP occupancy at the PIR3 TATA
were detected in the wild type strain. TBP occupancy was observed in the pir3 TTS-where
PIR3 mRNA levels are increased 2-fold-with no significant increase as compared to wild
type occupancy. It is possible that this small increase in TBP could account for the two-fold
increase in PIR3 expression, but that increase cannot be detected by ChIP. From this result,
it does not appear that intergenic transcription significantly interferes with TBP occupancy
at the PIR3 promoter.
I also examined TBP occupancy at the PIR3 ncRNA TATA sites using primers sets
designed to target the PIR3 ncRNA sites 1 and 3 (”ncRNA TATA1” and ”ncRNA TATA3,”
respectively), previously identified by genome-wide ChIP-exo data [63]. In both cases, the
signal for TBP occupancy is above background levels, particularly for TATA site 3. This
indicates a likely TATA box upstream of the PIR3 ncRNA. However, because of the resolu-
tion of ChIP I cannot distinguish between one or both TATA sequences contributing to TBP
binding. These two sites are candidates for TATA sequences that promote PIR3 ncRNA
synthesis.
43
Figure 4.7: Effects of intergenic transcription on TBP binding at the PIR3 pro-
moter. ChIP analaysis was performed using anti-TBP to characterize binding sites for PIR3
ORF and ncRNA. This quantitation is the result of three independent real-time PCR ex-
periments. Relative locations of primer sets are indicated on the diagram below the graph.
The control primer set, to which all values are normalized, amplifies a region of chromo-
some V that lacks open reading frames and represent the mean of three biological replicates
+/- SEM. Strains KY719, YJ1115 and YJ1116 (Wild type) and YJ1100, YJ1101, YJ1102
(pir3TTS) were grown at 30◦C to 1-2 X 107 cells/ml in YPD.
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4.8 INTERGENIC TRANSCRIPTION DOES NOT REGULATE PIR3
EXPRESSION IN RESPONSE TO CELL WALL STRESS
The role for PIR3 in maintaining cell wall integrity in times of cell wall stress may provide a
physiological mechanism for PIR3 regulation by intergenic transcription. Specifically, PIR3
expression has been shown to increase in response to elevated temperatures or in response
to cell wall perturbing agents such as congo red, zymolyase, or calcoflour white, in what is
speculated to be an Rlm1-dependent manner [30, 6, 19, 32].
To determine if PIR3 regulation by cell wall stress involves intergenic transcription, we
first assayed PIR3 ncRNA and PIR3 mRNA levels in response to heat shock. Wild type
cells were grown to mid-log at room temperature and then shifted to 39◦C, with time points
taken every 30 min for three hours. PIR3 ncRNA andPIR3 mRNA expression was assessed
by Northern analysis, with each time point compared to time 0 min (Figure 4.8). In response
to elevated temperatures, I observed increased PIR3 mRNA levels, as has been previously
described [30]. Interestingly PIR3 ncRNA levels also increased under these conditions. From
this result I can conclude that the increased expression of PIR3 in response to induction of
cell wall stress through elevated temperatures is independent of intergenic transcription.
Growth of yeast cells in the presence of caffeine has also been shown to activate cell wall
stress [76, 77, 47, 82, 38]. Therefore, I assayed changes in PIR3 ncRNA and PIR3 mRNA
after expression in caffeine by Northern analysis. Cells were grown to mid-log before adding
12mM caffeine. Time points were taken prior to caffeine addition and at 30 min intervals
after caffeine addition for three hours. Northern analysis shows increased PIR3 mRNA
by 30 min after addition of 12mM caffeine (Figure 4.9). Consistent with our temperature
experiment, expression of the ncRNA also increased in cell wall stress conditions. From this
result I can conclude that the increased expression of PIR3 in response to caffeine-induced
cell wall stress is independent of intergenic transcription.
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Figure 4.8: Increased expression of PIR3 in response to elevated temperatures
is independent of intergenic transcription. Northern analyses. (A) Strains KY710,
RMY104, RMY109 were grown at 25◦C in YPD to a density of 1 X 107 cells/ml before being
shifted to 39◦C by spinning cells down, removing media and re-suspending in pre-warmed
media. Samples were collected for RNA isolation at the indicated times. (B) Quantitation
of Northern in (A) from three biological replicates. PIR3 mRNA and ncRNA levels are
normalized to the SCR1 loading control and are relative to the PIR3 mRNA and ncRNA
levels measured at time 0 (arbitrarily set to 1).
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Figure 4.9: Increased expression of PIR3 in response to caffeine is independent
of intergenic transcription. Northern analyses. (A) Strains KY710, RMY104, RMY109
were grown at 30◦C in YPD to a density of 1 X 107 cells/ml prior to addition of 12mM
caffeine. Samples were collected for RNA isolation at the indicated times. (B) Quantitation
of Northern in (A) from three biological replicates. PIR3 mRNA and ncRNA levels are
normalized to the SCR1 loading control and are relative to the PIR3 mRNA and ncRNA
levels measured at time 0 (arbitrarily set to 1).
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4.9 CHROMATIN EFFECTS IN PIR3 NCRNA FUNCTION
Thus far, my data indicates that PIR3 is repressed by intergenic transcription. Several stud-
ies have indicated that ncRNA transcription regulates gene expression by altering chromatin.
SER3 repression has been shown to be regulated by intergenic transcription-dependent nu-
cleosome remodeling across the SER3 promoter [24]. Transcription of ncRNA can also lead
to repressive histone marks to control gene expression which has been described for the
divergently transcribed yeast GAL10 and GAL1 genes [27, 57].
To determine if chromatin structure could be causing repression of PIR3, I compared
PIR3 expression levels in cells expressing mutant forms of Spt16 (spt16-E857K ) or histone
H3 (H3 K122A) which are known to derepress SER3 by impaired SRG1 transcription-
dependent nucleosome assembly over the SER3 promoter. If chromatin structure is im-
portant for PIR3 repression, I would expect to see an increase in PIR3 expression in the
presence of these mutations. By Northern analysis, I observed a 2-fold (p < 0.08) increase
of the PIR3 mRNA in spt16-E857K mutant as compared to wild type SPT16 strain (Figure
4.10, lanes 1 and 2). However, no significant increase in expression of PIR3 mRNA was
observed for the histone H3 K122A mutants as compared to the wild type strain (Figure
4.10, lanes 3 and 4). Analysis of SER3 was performed as a control, with results similar to
previously described results [22, 21]. This may indicate that functional Spt16 is more im-
portant for PIR3 regulation than the histone H3 K122A mutation. The conflicting results
of these two mutants suggests one of two possibilities. First, PIR3 regulation by intergenic
transcription mediated by transcription-dependent changes in chromatin is more sensitive to
the Spt16 mutant than the histone H3 mutant. Alternatively, Spt16 may repress PIR3 by a
mechanism that is not related to its role in transcription-coupled nucleosome assembly.
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Figure 4.10: Analysis of the effects on gene expression in the presence of histone
H3 K122A and pspt16-E857K. (A) Representative Northern analysis of three indepen-
dent experiments assessing expression of the PIR3 and SER3 ORFs in strains harboring
mutations known to affect nucleosome occupancy at SER3. The mutant alleles are listed
above the blots. (B) Quantitation of Northern analyses. PIR3 and SER3 RNA levels for
the mutant strains are normalized to the SCR1 loading control and are relative to the PIR3
and SER3 RNA levels measured in wild type strains (arbitrarily set to 1). Strains YJ1091,
YJ1092, YS417, YS418, YS419, YS420, YS421, YS404 were grown at 30◦C to 1-2 X 107
cells/ml in YPD. SCR1 is used as the loading control.
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4.10 DELETIONS IN OTHER CHROMATIN-RELATED FACTORS HAVE
NO EFFECT ON PIR3 REPRESSION
Post-translation histone modifications prevent cyrptic intragenic transcription from occur-
ring in the wake of elongating RNA pol II across protein coding genes. Specifically, Set2
methylation of histone H3 on lysine 36 (H3 K36), a mark that occurs in the wake of elongat-
ing RNA pol II, recruits the Rpd3S histone deacetylase for the removal of acetylation marks
which returns chromatin to a transcriptionally inactive state. This series of events occurs
in the context of active transcription and is dependent on the Paf1C elongation complex.
Specifically, H2B K123 monoubiquitylation by the Rad6 ubiquitin conjugating enzyme and
the Bre1 ubiquitin ligase are necessary for downstream methyl marks by Set1 and Dot1
methyltransferases on H3 K4 and H3 K79, respectively. These marks are promoted by Paf1
and Rtf1 and are associated with active transcription. Additionally, H3 K4 di-methylation
occurs at 5’ ends of genes in the wake of elongation RNA pol II and leads to the recruitment
of the Set3 HDAC, which is also responsible for removal of histone acetyl marks (reviewed in
[13]). From this data, I hypothesized that regulation of PIR3 repression could be dependent
on histone modifications, whereby the PIR3 ncRNA is actively transcribed across the PIR3
promoter and the recruitment of histone deacteylases prevents transcription activation from
the PIR3 promoter. Evidence to support this model comes from the GAL1/GAL10 locus,
where a similar mechanisms of regulation by ncRNA occurs (reviewed in [23]).
To test this possibility, I performed Northern analysis to determine the effect that loss
of histone methyltransferases Set1, Set2, Dot1, and Rco1, an essential subunit of the Rpd3S
HDAC [10], have on PIR3 expression. I would expect to see increased PIR3 expression when
one or more of these genes are deleted if histone methylation is important for maintenance of
repression. Surprisingly, I found that both the PIR3 ncRNA and PIR3 mRNA levels were
reduced in these mutants. These results indicate that histone methylation is not involved
in PIR3 repression by intergenic transcription. Rather these marks are required for normal
transcription of both the PIR3 ncRNA and PIR3 mRNA.
I also tested the deletion mutants of Spt2 and Paf1, two factors that have also been
shown to be important for maintenance of repressive nucleosome occupancy at SER3
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[60, 72]. Spt2 binds DNA through an HMG (High Mobility Group)-like domain at transcrib-
ing regions, including SRG1/SER3, and has been shown to mediate chromatin dynamics [72].
I performed Northern analysis, which revealed decreased levels of both the PIR3 ncRNA as
well as PIR3 mRNA. These results indicate that chromatin associated activities of Spt2 or
Paf1 are not involved in PIR3 repression.
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Figure 4.11: Deletions in other chromatin-related factors have no effect on PIR3
repression. (A) Representative Northern analysis of three independent experiments assess-
ing PIR3 and ncRNA expression in wild type set1∆, set2∆, dot1∆, paf1∆, rco1∆, rtf1∆,
and spt2∆ strains. (B) Quantitation of results from a minimum of three biological replicates,
where error bars are given. Expression values are normalized to the SCR1 loading control
and made relative to the wild-type strains, arbitrarily set to 1. All strains were grown at
30◦C to 1-2 X 107 cells/ml in YPD.
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5.0 DISCUSSION
In this study, I provide evidence to support a new case of gene regulation by intergenic
transcription at the Saccharomyces cerevisiae PIR3 gene. Similar to our previous studies
of SER3, PIR3 repression by intergenic transcription occurs in cis. However, my results
suggest that intergenic transcription is repressing PIR3 through a different mechanism than
what is observed in SER3 repression [22, 24, 21, 60].
SER3 regulation has been shown to be dependent on nucleosome occupancy across its
promoter. Factors and histone residues found to be important for maintaining this repressive
architecture, include Paf1, Spt16, Spt2, and specific residues of histone H3
[22] [24, 21, 60, 72]. When these factors have been deleted or mutated, SER3 is no longer
repressed, even when SRG1 is being transcribed. This is due to loss of repressive nucleosome
occupancy at the SER3 promoter. If PIR3 expression were derepressed in strains with
deletion or mutations in these factors, it would have provided evidence for repression by
nucleosome occupancy at the PIR3 promoter. Deletions in paf1∆ and spt2∆ showed a
decrease in PIR3 expression. Additionally, no significant change in PIR3 mRNA levels in
the histone H3 K122A mutant was detected (Figures 4.10 and 4.11). This would suggest that
nucleosome occupancy at the PIR3 promoter is not mediating repression, which is different
from SER3 repression. However, the same 2-fold increase in PIR3 expression seen when
intergenic transcription is abolished by TTS insertion, was seen in the spt16-E857K mutant.
This would seem to support a role for nucleosome occupancy in PIR3 expression (Figure
4.10). Both the spt16-E857K and the histone H3 K122A mutations have been associated
with loss of histone H3 occupancy across the SER3 promoter. Furthermore, the histone H3
K122A and the spt16-E857K have been shown to reduce histone H3 occupancy at highly
transcribed genes, but not at lowly transcribed genes [24, 21]. Therefore, one possibility
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to account for the different effect of these mutants on PIR3 expression is that the level of
PIR3 ncRNA or PIR3 expression occur at some intermediate level, where there is a greater
sensitivity to defects in spt16-E857K than for the other factors. Alternatively, Spt16 has
a role at PIR3 independent of its role in transcription-coupled nucleosome occupancy. To
resolve these models, I need to examine the chromatin architecture at PIR3 by performing
histone ChIP experiments. In order to test the effects of spt16-E857K and histone H3 K122
have on nucleosome architecture at PIR3, I would need to perform ChIP analysis of histone
H3. If histone H3 occupancy is significantly decreased in the spt16-E857K mutant but
not in the histone H3 K122A strain, this would provide evidence for nucleosome-mediated
repression at PIR3 that is regulated by Spt16 activity. If I do not see any significant loss in
histone H3 occupancy in these experiments, it would provide support for some other role of
Spt16 in maintaining PIR3 repression.
It is possible that PIR3 repression is regulated by histone modifications coordinated by
transcription-dependent recruitment of histone modifying proteins. This mode of repression
by ncRNA is seen at the yeast GAL10/ GAL1 locus, where the Rpd3S HDAC is recruited
by histone H3 K4 di- and H3 K36 tri-methylation for removal of activating acetylation
modification at the GAL10/ GAL1 promoter (reviewed in [23]). Therefore, I investigated
the effects that loss of histone methyltransferases Set1, Set2, Dot1, and the Rpds3 subunit,
Rco1, have on PIR3 repression. I found that PIR3 repression by intergenic transcription
appears to be independent of histone methylation and the removal of histone acetylation
by the Rpd3S HDAC. In general, both a loss of PIR3 ncRNA and PIR3 mRNA expresion
is seen in this mutants. This indicates that histone modifications may be important for
maintaining normal levels of transcription, but not for maintaining repression by intergenic
transcription at PIR3.
Two other possible mechanisms of PIR3 repression include transcription interference
and promoter competition. If promoter competition were occurring, the promoter for the
PIR3 ncRNA would outcompete the PIR3 promoter for binding of transcription factors,
resulting in repressed PIR3 transcription [25]. However, promoter competition is likely not
the model for PIR3 repression, based on the increased PIR3 expression observed in the
pir3TTS strain. Transcription termination has no effect on PIC formation, as the promoter
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and regulatory elements are still in tact. Therefore, if promoter competition had been acting
in PIR3 repression, I would not have expected to see an increase in PIR3 expression upon
TTS insertion within the intergenic sequence because the intact intergenic promoter would
still outcompete the PIR3 promoter.
With promoter competition an unlikely model for PIR3 repression, I tested the hypoth-
esis that transcription interference by intergenic transcription may result in repression of
PIR3. To test this, I assessed the levels of TBP occupancy at the putative PIR3 consensus
TATA site. Since no significant increase in TBP occupancy at the PIR3 consensus TATA
site was seen in the absence of the ncRNA, I do not have strong evidence to support tran-
scription interference in blocking access of TBP at PIR3 (Figure 4.7). It is still possible that
intergenic transcription blocks access of other transcription factors. It is also possible that
TBP presence at PIR3 is in general low, making it difficult to see changes in TBP occupancy
using ChIP.
Interestingly, I found significant TBP occupancy at two TATA sequences 5’ of PIR3
ncRNA transcription start sites, indicating that these sequences may be the site of PIC
formation for intergenic transcription. The resolution of this ChIP is 200bp, and the distance
between PIR3 -ncTATA2 and PIR3 -ncTATA3 is only 99bp, making it difficult to say with
certainty which site TBP may be occupying. In the future, the TATA sites will need to be
mutated in order to make any conclusive arguments about PIC assembly sites. Once the the
ncTATA sites 1, 2, and 3 (Figure 4.1) have been mutated, I can assess whether loss of TBP
binding is associated with one of these TATA mutants to more accurately designate the true
regulatory elements. (See Materials and Methods for details on TATA mutations.)
It has been determined that PIR3 is upregulated in an Rlm1-dependent manner in
response to the cell wall integrity pathway [30]. This led me to hypothesize that ncRNA
at PIR3 may regulate PIR3 expression in response to cell wall stress through transcription
interference of this activator. If this were the case, I would have expected to see a decrease
in PIR3 ncRNA expression in concert with an increase in PIR3 expression when strains
were grown in cell wall stress-inducing conditions. This would support a model where loss of
intergenic transcription allows for binding of the Rlm1 activator protein to allow for increased
PIR3 expression to aid in stabilizing the cell wall. After growing cells in the stress inducing
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conditions of elevated temperatures and 12mM caffeine, both PIR3 ncRNA and PIR3 mRNA
expression were increased. This result does not support transcription interference of activator
binding as a model for regulation of PIR3 expression in response to cell wall stress. Although
this data does not exclude the possibility that intergenic transcription interferes with the
binding of some other activator, it does, however, refute Rlm1 involvement in inducing
PIR3 expression as a result of decreased intergenic transcription. In future experiments, I
will confirm that repression by intergenic transcription is not dependent on blocking Rlm1
binding by performing Northern analysis in rlm1∆ strains in elevated temperatures and
12mM caffeine. If Rlm1 is only involved in cell wall stress, I would likely see no change in
PIR3 expression, regardless of levels of intergenic transcription. In addition, I will compare
wild type to pir3TTS strains to prove if derepression of PIR3 by loss of intergenic transcription
is independent on Rlm1.
In order to further characterize regulation by intergenic transcription at PIR3, I at-
tempted to map the ncRNA and ORF transcription start sites. Using primer extension, I
found two potential start sites for both the PIR3 ncRNA and the PIR3 mRNA transcripts
(Figure 4.5). This data is preliminary and needs to be repeated.
To summarize, I have discovered a new source of repression in cis by intergenic transcrip-
tion at PIR3. A model for regulation in terms of how the ncRNA or the act of intergenic
transcription may be repressing PIR3 can only be speculated. Repression does not appear
to be mediated through chromatin structure, although comparing histone H3 ChIPs in the
presence and absence of spt16-E857K mutation will provide further evidence to support or
refute this model. Furthermore, histone modifications do not appear to be repressing PIR3.
The ncRNA TATA mutations at the PIR3 ncRNA should lead to a better understanding
of repression at PIR3. First, I will be able to confirm that the increased PIR3 expression I
see in the pir3TTS strains is due to loss of intergenic transcription and not some secondary
effect resulting from insertion of 171bp of the TTS sequence upstream ofPIR3. Secondly,
I will be able to confirm the correct TATA site for the intergenic transcript by repeating
the TBP ChIP analysis comparing wild type strain and each TATA mutant to determine
which site results in loss of TBP occupancy. Third, if promoter competition is operating at
PIR3, I would expect to see an even larger signal for PIR3 derepression. We cannot rule out
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promoter competition without preventing PIC formation at the ncRNA through mutation
of the regulatory elements.
During the course of this study, I have aided in the development of a method for dis-
rupting intergenic transcription through insertion of a minimal transcription termination
sequence (Figure 4.3). The utility of this method was confirmed at SER3. Briefly, I inserted
171bp of the HIS3 -TTS at -450bp upstream of the SER3 ATG, within the SRG1 sequence.
I demonstrated a loss of SRG1 with concurrent derepression of SER3 despite growth in high
serine conditions. This shows that by abolishing SRG1 transcirption with the TTS, I also
disrupted the repressive nucleosome occupancy at the SER3 promoter. Having confirmed the
efficacy of this method, I employed it at PIR3. With insertion of the TTS at -486bp, relative
to the PIR3 ATG, I was able to establish that repression by intergenic transcription was
occurring. This method could prove useful for studying the effects of disrupted transcription
at any nonessential gene. The advantage to using the HIS3 -TTS to disrupt transcription is
that mutational analysis of regulatory sequences is not needed, faciliting studies where these
sites are unknown, as was the case for PIR3. A caveat, however, is the fact that 171bp of
DNA sequence is added to the site under investigation. If sequence structure is important
in regulating expression, this method may not lead to identification of true mechanisms of
gene expression.
Studying mechanisms of gene regulation by ncRNA will lead to a greater understanding of 
their role in disease and development. ncRNAs have been shown to have importance in neural 
function, cellular development, and cancer (Reviewed in [61, 50, 3, 75][59]). The discovery of 
these ncRNAs was made possible by improved technologies for transcriptome analysis [50][3]. 
As technologies advance that can identify RNAs expressed within particular cells at par-
ticular times, the number of genes identified to be regulated by ncRNA will likely increase. 
Ideally, current studies of gene regulation by ncRNA will provide guidelines for identifying 
and studying these new ncRNAs. Additionally, these ncRNA can be used as targets in 
treating disease or as biomarkers, as is the case with certain cancers or neurological function 
(Reviewed in [61, 59]). For example, a ncRNA that is aberrantly expressed, resulting in 
disease development, could be targeted by RNA silencing technologies. On the other hand,
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if a ncRNA has been shown to be present in high levels in aggressive cancers, this biomarker
could be useful in deciding to treat a patient more aggressively despite adverse side effects.
Thus, studying gene regulation by ncRNAs will lead to improved understanding and treat-
ment of disease.
PIR3 does not appear to be regulated by ncRNA in response to cell wall stress; how-
ever, the fact that this study involved gene regulation important in cell wall synthesis may
have implications beyond noncoding RNA. Certain yeast species, such as Candida albicans,
Aspergillus fumigatus, and Cryptococcus neoformans, act as human pathogens. S. cerevisae
serves as a model for yeast pathogens, due to conservation in cell wall construction and stress
signaling, especially in C. albicans [41]. With increases in the number of fungal infections as
well as increases in antifungal resistance since the 1990’s [56], improving our knowledge of
cell wall biogenesis and regulation could aid in the development of more effective treatments
for pathogenic yeast, especially in immune compromised people.
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APPENDIX
NON-SPECIFIC BAND FOR PIR3 NORTHERN PROBE
In my initial studies, I thought that, in addition to the increase in PIR3 expression in
the pir3TTS strain, a second larger transcript was expressed at PIR3 by Northern analysis.
However, I began to see this band in the wild type strains as well as inconsistencies in the
bands appearance in pir3TTS strain. This prompted me to assess transcript signals from the
PIR3 probe in a pir3∆ strain. In the Northern analysis, I saw the larger band even when
PIR3 was deleted, indicating that this signal is non-specific (Figure A1). I continued to
use this probe despite this result since I wanted a probe within the PIR3 ORF that had
no overlap with untranslated regions, and attempts to design other probes had homology to
PIR1.
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Figure A1: Northern analysis assessing the specificity of PIR3 probe used pir3∆
from ko collection.
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